VS on presentation were 97.9 128/60 97 28 94%ra.
He had a CXR and a chest CTA that was neg for PE but concerning for worsened pleural effusions bilaterally, lymphangetic spread of tumor, and a possible post-obstructive pneumonia.
He became increasingly dyspneic and hypoxic in the ED, satting 87% on ra, and was placed on a NRB (satting in the 90s and then bipap with significant improvement.
Stage IV EML4-ALK (E13A20 ??????
Deep vein thrombosis of the upper extremity diagnosed in [**2153-10-11**] (likely related to his stage IV nonsmall cell lung cancer).
Status post 2 cycles of 1st line systemic chemotherapy with Carboplatin 6 AUC D1 and Gemcitabine 1000 mg/m2 D1,8 of 3 week cycle in [**2152**] (had progressive disease).
Continues to take study drug.
ALT(SGPT)-246* AST(SGOT)-81* LD(LDH)-355* CK(CPK)-94 ALK PHOS-141* TOT BILI-1.5 ALBUMIN-2.5* .
GLUCOSE-111* UREA N-21* CREAT-1.0 SODIUM-134 POTASSIUM-4.3 CHLORIDE-100 TOTAL CO2-27 .
Discharge: WBC-8.3 Hct-33.4* MCV-69* Plt Ct-87* .
Type-ART pO2-219* pCO2-37 pH-7.46* calTCO2-27 Base XS-3 .
CTA [**2155-8-10**]: 1.
ECHO [**2155-8-11**]: The left atrium is normal in size.
CXR [**2155-8-13**]: IMPRESSION: Relatively stable radiographic examination with slight accentuation of the interstitial markings most notably on the right.
Dyspnea was most likely due to fluid reaccumulation and progression of cancer, however vanc/zosyn was started for a 7 day course for possible post-obstructive pneumonia.
On [**8-12**] pt had a right thoracentesis with 1200 ml serous fluid removed.
He was to follow up with IP within 1 week for evaluation for pleurodesis and to see his oncologist on [**2155-8-28**].
# Non-small cell lung cancer: has known metastases to brain and liver, recent drainage of a malignant right pleural effusion, ?worsening lymphangitic spread on chest CT, and initiation of new chemotherapeutic [**Doctor Last Name 360**] in the setting of progression.
